Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-24T05:47:48.239Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of antipsychotics by child and adolescent psychiatrists

Published online by Cambridge University Press:  02 January 2018

Karmen Slaveska ,
Chris Hollis  and
David Bramble
Karmen Slaveska*
Affiliation:
Department of Child and Adolescent Psychiatry, South Block, E Floor, Queen's Medical Centre, Nottingham NG7 2UH
Chris Hollis
Affiliation:
Department of Child and Adolescent Psychiatry, South Block, E Floor, Queen's Medical Centre, Nottingham NG7 2UH
David Bramble
Affiliation:
Department of Child and Adolescent Psychiatry, South Block, E Floor, Queen's Medical Centre, Nottingham NG7 2UH
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aims and methods

A postal questionnaire of Trent Region's consultant child and adolescent psychiatrists was used to investigate the two-year period prevalence rates of antipsychotic medication prescription, and the ICD–10 psychiatric disorders it was used to treat.

Results

The response rate was good (92.3%) and 78% of respondents had prescribed antipsychotic medication for a range of conditions over the period, albeit very infrequently. Antipsychotics were used for a range of psychotic and non-psychotic disorders. The older antipsychotic agents (thioridazine, chlorpromazine and haloperidol) comprised the bulk of prescriptions. Newer, atypical, antipsychotics were prescribed only four times over the period and no patients in residential in-patient units received this form of treatment.

Clinical implications

These results highlight a pressing need to address antipsychotic prescribing in children and adolescents and, especially, the role of new antipsychotic drugs.

Type
Original Papers
Information
Psychiatric Bulletin , Volume 22 , Issue 11 , November 1998 , pp. 685 - 687
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1998 The Royal College of Psychiatrists

References

Birmaher, B., Baker, R., Kapur, S., et al (1992) Clozapine for the treatment of adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 160–164.CrossRefGoogle ScholarPubMed
Campbell, M., Grega, D. M., Green, W. H., et al (1983) Neuroleptic induced dyskinesias in children. Clinical Neuropharmacology, 6, 207–222.CrossRefGoogle ScholarPubMed
Green, W. H., Padron-Gayol, M., Hardesty, A. S., et al (1992) Schizophrenia with childhood onset. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 968–976.CrossRefGoogle ScholarPubMed
James, A. C. (1996) A survey of prescribing practises of child and adolescent psychiatrists. Child Psychology and Psychiatry Review, 1, 94–97.Google Scholar
Kerwin, R. (1994) The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research. British Journal of Psychiatry, 164, 141–148.CrossRefGoogle ScholarPubMed
Kerwin, R. (1996) An essay on the use of new antipsychotics. Psychiatric Bulletin, 20, 23–26.CrossRefGoogle Scholar
Kumra, S., Frazier, J. A., Jacobsen, L. K., et al (1996) Childhood-onset schizophrenia. A double blind clozapine-haloperidol comparison, Archives of General Psychiatry, 53, 1090–1997.CrossRefGoogle ScholarPubMed
Leiberman, J. A., Safferman, A. Z., Pollack, S., et al (1994) Clinical effect of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. American Journal of Psychiatry, 151, 1744–1752.Google Scholar
Lowe, K., Smith, H. & Clark, A. (1996) Neuroleptic prescribing in an adolescent psychiatric in-patient unit. Psychiatric Bulletin, 20, 538–540.CrossRefGoogle Scholar
Mozes, T., Toren, P., Chernauzan, N., et al (1994) Clozapine treatment in very early-onset schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 65–70.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.